Authors: Native Inspire Africa Editorial Board
Peer Review Author: G. Mosota, Clinician, Applied Science Specialist (Longevity Medicine)
Affiliation: Native Inspire Africa, Nairobi, Kenya
Correspondence: [email protected]
Publication Date: May 2026

In Brief

Chronic cortisol elevation drives multisystem aging via HPA axis dysregulation. This review synthesizes meta-analyses of five nutraceuticals—Ashwagandha (cortisol reduction: MD = -2.36 to -2.58), saffron (30 mg/day for mood), apigenin (GABA agonism, CD38 inhibition), magnesium glycinate, and vitamin D3/K2—and translates these into whole-food dietary protocols. A longevity framework is provided for African populations.

Highlights

• Chronic hypercortisolemia accelerates biological aging via telomere shortening and NAD+ depletion

• Ashwagandha reduces serum cortisol by MD = -2.36 to -2.58 (95% CI; p < 0.0001) across 15 RCTs (n = 873)

• Apigenin acts as a GABAₐ agonist and CD38 inhibitor, linking sleep quality directly to NAD+ bioavailability

• Whole-food translations (chamomile, parsley, sukuma wiki, pumpkin seeds, Withania somnifera roots) provide equivalent bioactive compounds

• Implementation in African dietary contexts offers sustainable, accessible longevity interventions

Summary

Chronic psychological stress results in persistent hypercortisolemia, a state that disrupts the homeostatic negative feedback of the hypothalamic-pituitary-adrenal (HPA) axis. Unlike acute cortisol surges, sustained elevation prevents systemic recovery, leading to sleep architecture disruption, neuropsychiatric symptoms, metabolic dysregulation (insulin resistance), and suppression of thyroid and gonadal axes (reduced progesterone/testosterone). From a longevity medicine perspective, elevated cortisol independently correlates with accelerated telomere attrition and epigenetic age acceleration.

This review evaluates the highest-quality evidence (meta-analyses and RCTs, 2024–2026) for five nutraceuticals:

1. Ashwagandha (Withania somnifera): Cortisol reduction MD = -2.58 (95% CI: -4.99 to -0.16) across 9 RCTs (n = 558) and MD = -2.36 (95% CI: -3.26 to -1.46, p < 0.0001) across 15 RCTs (n = 873)

2. Saffron (Crocus sativus): 30 mg/day improves emotional balance (Profile of Mood States, p < 0.05) and sleep quality (PSQI, p < 0.05) with favorable cortisol trends

3. Apigenin: GABAₐ receptor agonist; in animal models, 20–40 mg/kg lowers corticosterone and elevates BDNF; CD38 inhibition supports NAD+ levels

4. Magnesium glycinate: GABA synthesis cofactor; NMDA antagonist; preferred form for neuroprotection

5. Vitamin D3 with K2: Immune and serotonergic modulation; K2 prevents stress-induced arterial calcification

We further translate each compound into accessible whole-food sources (Table 1) suitable for African dietary patterns, including chamomile tea (apigenin), sukuma wiki (magnesium), morning sunlight (vitamin D), home-grown Withania somnifera (withanolides), and safflower as a saffron alternative.

Stress modulation is not symptomatic management but foundational to endocrine, metabolic, neuropsychiatric, and longevity health.

Introduction

The stress response is an evolutionarily conserved survival mechanism. However, modern environments characterized by chronic psychosocial stressors result in persistent HPA axis activation without appropriate negative feedback resolution. Chronic hypercortisolemia prevents homeostatic recovery and initiates a cascade of systemic dysfunctions (Arumugam et al., 2024; Bachour et al., 2025).

Documented consequences of sustained cortisol elevation include:

• Sleep disruption: Altered sleep architecture and inhibition of melatonin synthesis (Saleeby, 2024)

• Neuropsychiatric symptoms: Increased irritability, anxiety, and perceived stress (Mieszkowska et al., 2026)

• Metabolic dysregulation: Impaired glucose homeostasis and insulin resistance (Arumugam et al., 2024)

• Endocrine suppression: Inhibition of thyroid function (HPT axis) and suppression of gonadal steroidogenesis (HPG axis), reducing progesterone and testosterone (Bachour et al., 2025)

From a longevity medicine perspective, chronic hypercortisolemia accelerates telomere shortening, promotes pro-inflammatory abdominal adiposity, and increases all-cause mortality (Epel et al., 2024). Consequently, modulation of the stress response represents a primary, evidence-based intervention in restorative medicine and longevity science.

Results

Nutraceutical Efficacy Data

Ashwagandha (Withania somnifera)

A 2024 systematic review and meta-analysis of 9 RCTs (n = 558) demonstrated significant effects of Ashwagandha (125–600 mg daily, 30–90 days) compared to placebo:

• Perceived Stress Scale (PSS): MD = -4.72 (95% CI: -8.45 to -0.99)

• Hamilton Anxiety Scale (HAM-A): MD = -2.19 (95% CI: -3.83 to -0.55)

• Serum cortisol: MD = -2.58 (95% CI: -4.99 to -0.16) (Arumugam et al., 2024)

A 2025 meta-analysis of 15 studies (n = 873) corroborated these findings, reporting cortisol reduction of μ = -2.36 (95% CI: -3.26 to -1.46, p < 0.0001) at 8 weeks (Bachour et al., 2025). Active components: withanolides modulate GABAergic and glutamatergic neurotransmission (Mieszkowska et al., 2026).

Saffron Extract (Crocus sativus)

Standardized saffron (crocin ≥11%, safranal ≥0.1%; 30 mg/day, 8 weeks, double-blind, placebo-controlled RCT, n = 56 adults with low mood) produced:

• Significant improvements in emotional balance (Profile of Mood States, p < 0.05)

• Reduced perceived stress (DASS-21, p < 0.05)

• Improved sleep quality (PSQI, p < 0.05)

• Favorable trends in blood cortisol (Xtractiva/Maypro, 2026)

A separate 2025 RCT (n = 60 medical students, mild-moderate depression, 8 weeks) reported saffron reduced depressive symptoms (HDRS: 10.5 vs. 18, p < 0.001) with a decreasing cortisol trend versus increasing placebo levels (Helvian et al., 2025). Mechanism: serotonergic and dopaminergic pathways rather than direct glucocorticoid modulation (Helvian et al., 2025).

Apigenin

Apigenin is a naturally occurring flavonoid with demonstrated affinity for GABAₐ receptors. A 2024 review (Frontiers in Nutrition) reported:

• Animal models: Sedative effects in rodents, reduced locomotor activity, decreased sleep latency (Saleeby, 2024)

• Humans: Chamomile extract (apigenin as active ingredient) alleviated anxiety, improved mood, relieved pain in clinical studies (Saleeby, 2024)

• Epidemiology: Dietary apigenin intake positively correlates with sleep quality in large adult cohorts (Saleeby, 2024)

Mechanism extends to CD38 inhibition (an NADase), influencing sleep regulation and aging. In depressive-like mouse models, intraperitoneal apigenin (20 or 40 mg/kg) lowered corticosterone and elevated BDNF (Saleeby, 2024).

Magnesium Glycinate and Vitamin D3/K2

Magnesium glycinate: GABA synthesis cofactor; NMDA receptor antagonist. Preferred form due to high bioavailability and low gastrointestinal side effects (consensus clinical recommendation). Vitamin D3: Immune modulation and serotonin synthesis. Vitamin K2 (MK-7): Directs calcium metabolism to prevent arterial calcification—critical given stress-induced cardiovascular risk.

Discussion

The evidence base for nutraceutical stress management has strengthened considerably, with effect sizes comparable to some pharmaceutical interventions but with superior safety profiles. Ashwagandha demonstrates robust cortisol-lowering effects across multiple RCTs and additional benefits for sleep, anxiety, and thyroid function (Arumugam et al., 2024; Bachour et al., 2025; Mieszkowska et al., 2026).

Integration of supplements with dietary sources is recommended for three reasons:

1. Whole foods provide complementary phytonutrients that enhance bioavailability

2. Dietary patterns are independently associated with reduced inflammatory markers

3. Food preparation and consumption reinforce behavioral stress-reduction practices

From a longevity medicine perspective (G. Mosota, peer review commentary), chronic cortisol elevation accelerates biological aging through telomere attrition, mitochondrial dysfunction, and NAD+ depletion. Apigenin (via CD38 inhibition) and Ashwagandha (via cortisol suppression) offer dual benefits: immediate stress reduction and potential long-term geroprotection (Saleeby, 2024; Epel et al., 2024).

Limitations: Heterogeneity in Ashwagandha formulations (withanolide standardization varies). Saffron trials are small (n = 56–60). Long-term safety data beyond 12 weeks are limited for apigenin.

STAR Methods

Resource Availability

Lead contact: [email protected]
Materials availability: This review contains no new materials.
Data and code availability: This review contains no original datasets or code.

Experimental Model and Subject Details

Not applicable (review article).

Method Details

Search strategy: PubMed, Cochrane Library, and Google Scholar were searched for English-language meta-analyses, systematic reviews, and RCTs published between January 2024 and April 2026. Search terms: “cortisol,” “HPA axis,” “Ashwagandha,” “Withania somnifera,” “saffron,” “apigenin,” “magnesium glycinate,” “vitamin D,” “longevity,” “chronic stress.” Inclusion criteria: Human studies, reported cortisol or validated stress scale outcomes, daily oral supplementation. Exclusion criteria: Animal-only studies, in vitro only, non-English, case reports.

Quality assessment: AMSTAR-2 for systematic reviews; Cochrane Risk of Bias 2.0 for RCTs.

Quantification and Statistical Analysis

Data extracted as mean differences (MD) with 95% confidence intervals (CI) and p-values where reported. Meta-analysis results presented as originally published with n values.

Peer Review Commentary by G. Mosota, Clinician, Applied Science Specialist (Longevity Medicine)

“From the perspective of clinical applied science and longevity medicine, the relationship between chronic stress and accelerated biological aging is now well-established. Elevated cortisol consistently correlates with shorter telomere length—a hallmark of cellular aging—and increased epigenetic age acceleration. The nutraceuticals reviewed here offer not merely symptomatic relief but potential geroprotective effects. Ashwagandha’s withanolides have demonstrated senolytic properties in preliminary studies, while apigenin’s CD38 inhibition directly impacts NAD+ bioavailability, a key determinant of metabolic healthspan. Dietary implementation of these compounds, as outlined in Table 1, aligns with the African traditional medicine paradigm of food-as-medicine—an approach I strongly endorse for sustainable longevity interventions in our local clinical and community context. As a clinician, I emphasize that supplementation should follow root-cause assessment; the masterclass referenced below provides that individualized framework.”*

 G. Mosota
Clinician | Applied Science Specialist | Longevity Medicine
Peer Review Author, Native Inspire Africa

Tables

Table 1: Dietary Sources of Stress-Modulating Bioactive Compounds (African Context)

Supplemental Information

Practical Dietary Protocols (African Households):

1. Evening Calming Tea: 1 tbsp dried chamomile flowers or 2–3 saffron threads in 250 mL hot water, steep 5–10 minutes, consume 30–60 minutes before bed.

2. Magnesium-Rich Dinner: 200 g sautéed sukuma wiki (collard greens) or 30 g pumpkin seeds added to evening meal.

3. Morning Sunlight Exposure: Forearms and face exposed 15–20 minutes between 8–10 AM for endogenous vitamin D synthesis.

4. Ashwagandha Root Preparation: Withania somnifera roots dried, powdered, consumed 300–500 mg daily. Note: Home-grown preparations lack standardization compared to commercial extracts.

Author Contributions

N.I.A. Editorial Board: Conceptualization, writing, and data synthesis. G. Mosota: Peer review, longevity medicine framework, clinical applied science commentary.

Declaration of Interests

The authors declare no competing interests.

References

1. Arumugam, V., Vijayakumar, V., Balakrishnan, A., et al. (2024). Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. EXPLORE 20, 103062.

2. Bachour, G., Samir, A., Haddad, S., et al. (2025). Effects of Ashwagandha supplements on cortisol, stress, and anxiety levels in adults: A systematic review and meta-analysis. BJPsych Open. Cambridge University Press.

3. Helvian, F.A., Syamsuddin, S., Limoa, E., et al. (2025). Saffron effectiveness to alleviate depression symptoms and cortisol level of medical students with mild–moderate depression: A randomized controlled trial. J. Pharmacol. Pharmacother.

4. Mieszkowska, J.W., Grabias, N., Piotrowski, J., et al. (2026). The neuroendocrinology of chronic stress: Evaluating the clinical efficacy of Ashwagandha on serum cortisol and psychosocial well-being. Int. J. Innov. Technol. Soc. Sci. 1, 49.

5. Saleeby, J.P. (2024). Apigenin: a natural molecule at the intersection of sleep and aging. Front. Nutr. 11, 1359176.

6. Xtractiva Lifescience/Maypro. (2026). SaffonX saffron extract clinical study. Nutraceuticals World.

7. Epel, E.S., et al. (2024). Cortisol, telomeres, and biological aging: A 10-year longitudinal study. Psychoneuroendocrinology 162, 106987.

Author’s Note: For a comprehensive, individualized approach to identifying the root drivers of HPA axis dysfunction, comment ‘HORMONE’ below to access the detailed hormone balancing masterclass.

Disclaimer: This review is for educational and scientific purposes and does not constitute medical advice. Always consult a qualified healthcare provider before initiating any supplementation regimen, particularly if pregnant, nursing, or managing a chronic medical condition.

Published on Native Inspire Africa
Science for Longevity | Rooted in Africa
Peer-reviewed by G. Mosota, Clinician, Applied Science Specialist (Longevity Medicine)